Setting The Standard: How Sanofi India Yielded 1991% Returns
Had you invested ₹1 lakh in Sanofi in December 2002, your capital would have grown to ₹27.38 lakhs today. Meet the multibagger that gave its investors returns of ₹19,91,720 and dividends of ₹7,47,189. Here’s a closer look at the company.
💉 Stock Name: Sanofi India Ltd.
💉 NSE: $SANOFI
⭐ About The Company
Founded in May 1956, Sanofi India is the establishment of Sanofi, a French pharmaceutical company. Formerly known as Hoechst Fedco Pharma, Sanofi India is one of the major multinational organizations in the pharmaceutical industry in India, providing a range of medicines, healthcare goods & services and preventive health vaccines. Sanofi India is majorly owned by Sanofi and its 100% subsidiary Hoechst GmbH.
🌏 Market Giant
Headquartered in Mumbai, Sanofi India has established itself as a household name for the treatment of allergies and pain relief. The company has such a presence that every second child in the country receives its inactivated polio vaccine. It operates through three manufacturing facilities located in Hyderabad and Goa. It also has a development centre. On the manufacturing side, Sanofi India sells APIs, vaccines, medical devices and finished formulations in more than 60 countries.
Sanofi India specializes in therapeutic pharmaceutical solutions to aid cardiology issues, diabetes and thrombosis. Four of its products are among the top 100 pharmaceutical brands in India. In addition to the company’s manufacturing facilities, Sanofi India is also connected to a number of independent contractors all over India. Sanofi India earned revenue of ₹692 crores and made a profit of ₹131 crores.
🔮 Future Plans
The company aims to increase its operating income margin to 32% by 2025. A series of cost-cutting initiatives are underway for the company, including the discontinuation of research in diabetes and cardiovascular pharmacy. The company will focus on the efficient allocation of resources as well as a change in the modus operandi of its manufacturing processes. Implementation of these measures is expected to create savings of 2 billion euros.
💰 Stock Value
On December 6, 2002, the shares of the company were trading at ₹273.05, while they were priced at ₹5711.45 as of December 5, 2022.